Conference Coverage

Biomarkers are being harnessed to improve colorectal cancer detection

Publish date: August 14, 2015

 

AT PMO LIVE

References

Dr. Roy disclosed that he receives a salary from NanoCytomics, and has an ownership interest in American BioOptics, NanoCytomics, and Pegasus Biosolutions.

Pages

Recommended Reading

ASCO 2015: from data and learning, to daily practice
MDedge Hematology and Oncology
Harnessing new data on immunotherapies
MDedge Hematology and Oncology
Hereditary cancer syndromes highly prevalent in young adults with colorectal cancer
MDedge Hematology and Oncology
Targeting H. pylori may help prevent stomach cancer
MDedge Hematology and Oncology
Persistent HPV16 DNA in oral rinse signaled oropharyngeal cancer’s return
MDedge Hematology and Oncology
New guidelines stress identifying Lynch syndrome
MDedge Hematology and Oncology
Elderly LARC patients had similar nCRT outcomes to younger patients
MDedge Hematology and Oncology
Esophagogastric cancer chemotherapy commonly causes VTE
MDedge Hematology and Oncology
Intestinal obstruction risk increased in some childhood cancer survivors
MDedge Hematology and Oncology
FIRE-3: Drug sequence plays role in mCRC outcomes
MDedge Hematology and Oncology